Research programme: tetracycline antimalarials - Paratek
Alternative Names: Antimalarials research programme - Paratek/MMV; Tetracycline antimalarials research programme - Paratek/University of California at San Francisco; Tetracycline antimalarials research programme - Paratek/USCFLatest Information Update: 26 Sep 2023
At a glance
- Originator Paratek Pharmaceuticals
- Class Tetracyclines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria